Tower Research Capital LLC (Trc) Liquidia Corp Transaction History

Tower Research Capital LLC (Trc)

$3.39 Billion
Q3 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Liquidia Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,877 shares of LQDA stock, worth $82,224. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,877

Previous 6,679 56.92%

Holding current value

$82,224

Previous $83,000 20.48%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$12.06 - $28.85 $45,852 - $109,687	-3,802 Reduced 56.92%	2,877 $66,000
Q2 2025 Aug 14, 2025	BUY	$11.99 - $19.3 $59,074 - $95,091	4,927 Added 281.22%	6,679 $83,000
Q1 2025 May 15, 2025	BUY	$11.36 - $16.5 $11,166 - $16,219	983 Added 127.83%	1,752 $25,000
Q4 2024 Feb 13, 2025	SELL	$9.82 - $11.8 $12,019 - $14,443	-1,224 Reduced 61.41%	769 $9,000
Q3 2024 Nov 14, 2024	SELL	$8.9 - $14.11 $33,971 - $53,857	-3,817 Reduced 65.7%	1,993 $19,000

Q2 2024 Aug 13, 2024	BUY	$11.96 - $15.71 $46,512 - $61,096	3,889 Added 202.45%	5,810 $69,000
Q1 2024 May 15, 2024	SELL	$11.35 - $16.73 $80,312 - $118,381	-7,076 Reduced 78.65%	1,921 $28,000
Q4 2023 Feb 13, 2024	BUY	$5.77 - $12.19 $44,607 - $94,240	7,731 Added 610.66%	8,997 $108,000
Q3 2023 Nov 14, 2023	SELL	$6.27 - $8.15 $35,977 - $46,764	-5,738 Reduced 81.92%	1,266 $8,000
Q2 2023 Aug 14, 2023	BUY	$6.63 - $9.9 $23,364 - $34,887	3,524 Added 101.26%	7,004 $54,000
Q1 2023 May 09, 2023	SELL	$5.72 - $7.91 $36,653 - $50,687	-6,408 Reduced 64.81%	3,480 $24,000
Q4 2022 Feb 10, 2023	SELL	$4.68 - $6.54 $71,112 - $99,375	-15,195 Reduced 60.58%	9,888 $63,000
Q3 2022 Nov 10, 2022	BUY	$3.73 - $8.39 $85,506 - $192,332	22,924 Added 1061.79%	25,083 $136,000
Q2 2022 Aug 15, 2022	SELL	$3.37 - $7.55 $37,218 - $83,382	-11,044 Reduced 83.65%	2,159 $9,000
Q1 2022 May 12, 2022	BUY	$5.14 - $7.38 $67,863 - $97,438	13,203 New	13,203 $95,000
Q4 2021 Feb 14, 2022	SELL	$2.71 - $5.17 $7,268 - $13,865	-2,682 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.28 - $2.95 $7,387 - $9,558	-3,240 Reduced 54.71%	2,682 $7,000
Q2 2021 Aug 16, 2021	SELL	$2.51 - $3.11 $23,051 - $28,562	-9,184 Reduced 60.8%	5,922 $17,000
Q1 2021 May 17, 2021	BUY	$2.42 - $3.6 $22,680 - $33,739	9,372 Added 163.45%	15,106 $41,000
Q4 2020 Feb 16, 2021	SELL	$2.6 - $5.79 $47,785 - $106,414	-18,379 Reduced 76.22%	5,734 $17,000
Q3 2020 Nov 16, 2020	BUY	$4.34 - $8.28 $88,692 - $169,210	20,436 Added 555.78%	24,113 $119,000
Q2 2020 Aug 13, 2020	BUY	$4.86 - $11.44 $13,593 - $31,997	2,797 Added 317.84%	3,677 $31,000
Q1 2020 May 15, 2020	BUY	$3.31 - $7.15 $2,581 - $5,577	780 Added 780.0%	880 $4,000
Q4 2019 Feb 07, 2020	SELL	$3.07 - $5.11 $561 - $935	-183 Reduced 64.66%	100 $0
Q3 2019 Nov 05, 2019	BUY	$3.29 - $8.24 $931 - $2,331	283 New	283 $1,000
Q1 2019 May 14, 2019	SELL	$10.82 - $21.79 $1,082 - $2,179	-100 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$16.38 - $37.18 $1,638 - $3,718	100 New	100 $2,000

Others Institutions Holding LQDA

# of Institutions

237

Shares Held

54M

Call Options Held

6.33M

Put Options Held

7.87M

View Full List

About Liquidia Corp

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $1.84B
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

More about LQDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Liquidia Corp Transaction History